Table 1.

Baseline characteristic of patients with ICG-R15 ≥ 10% or ICG-R15 < 10%

Before propensity matching				After propensity matching
	≥ 10% (n = 97)	< 10% (n = 203)	p-value	≥ 10% (n = 58)	< 10% (n = 58)	p-value
Age (Y)	55.57 ± 11.12	51.68 ± 12.24	0.009*	55.07 ± 11.65	54.09 ± 12.03	0.656
Sex (male, %)	72 (74.23%)	167 (82.27%)	0.106	45 (77.59%)	52 (89.66%)	0.079
BMI	23.39 ± 3.24	22.93 ± 3.07	0.232	23.53 ± 3.31	22.55 ± 3.39	0.117
HGB (g/L)	128.52 ± 25.66	138.49 ± 23.92	0.001*	131.76 ± 28.53	134.57 ± 25.56	0.578
WBC(× 109 /L)	4.96 ± 2.54	5.72 ± 1.86	0.005*	5.37 ± 2.81	5.41 ± 2.03	0.928
PLT (× 109 /L)	112.62 ± 72.50	153.88 ± 76.22	< 0.001*	122.19 ± 60.93	138.29 ± 77.14	0.215
HBV (positive, %)	77 (79.38%)	145 (71.43%)	0.241	48 (82.76%)	41 (70.69%)	0.125
Tb (μmol/L)	23.58 ± 12.90	15.88 ± 7.81	< 0.001*	18.80 ± 9.44	19.47 ± 10.32	0.716
AST (median IU/L)	56.0 (39.0–74.0)	42.0 (27.0–62.0)	< 0.001*	49.00 (37.75–71.75)	52.50 (32.50–71.05)	0.722
ALT (median IU/L)	45.0 (27.0–71.0)	39.0 (22.0–60.0)	0.030*	41.50 (27.00–55.25)	44.50 (21.75–84.25)	0.647
ALB (g/L)	36.8 ± 4.85	41.12 ± 4.38	< 0.001*	38.25 ± 4.61	38.15 ± 3.99	0.897
PT(s)	12.28 ± 1.12	12.59 ± 1.49	0.071	12.64 ± 1.40	12.57 ± 1.11	0.753
TV (mL)	78.9 (22.49–386.29)	130.(45.99–405.99)	0.137	88.86 (25.25–451.53)	156 (81.04–611.76)	0.107
RLV (mL)	1152.65 ± 358.80	1121.30 ± 268.05	0.398	1128.72 ± 292.35	1122.33 ± 326.21	0.912
SV (mL)	471.57 ± 282.31	284.12 ± 180.39	< 0.001*	414.41 ± 210.77	324.82 ± 206.34	0.023*
BSA	1.66 (1.55–1.75)	1.65 (1.53–1.77)	0.797	1.67 (1.58–1.76)	1.63 (1.52–1.77)	0.344
SNLV	703.85 ± 215.92	673.60 ± 140.22	0.147	689.79 ± 167.03	676.81 ± 166.46	0.805
SNLR	0.44 ± 0.29	0.26 ± 0.16	< 0.001*	0.38 ± 0.22	0.30 ± 0.18	0.029*

^* Reflecting the difference was significant in statistics (p < 0.05)